MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

20 May 2023 Evaluate
The total revenue stands at Rs. 3.16 millions for the March 2023 quarter. The mentioned figure indicates an increase of about 116.44% as against Rs. 1.46 millions during  the year-ago period.The company almost doubled its revenue to Rs. 1.96 millions  from Rs. 0.34 millions in the quarter ended March 2023.A decline of 2.62 millions was observed in the OP in the quarter ended March 2023 from 5.27 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3.16 1.46 116.44 10.19 3.65 179.18 10.19 3.65 179.18
Other Income 4.16 7.06 -41.08 17.51 19.19 -8.75 17.51 19.19 -8.75
PBIDT 2.62 5.27 -50.28 10.60 10.25 3.41 10.60 10.25 3.41
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.62 5.27 -50.28 10.60 10.25 3.41 10.60 10.25 3.41
Depreciation 0.24 0.37 -35.14 0.94 0.92 2.17 0.94 0.92 2.17
PBT 2.38 4.90 -51.43 9.66 9.33 3.54 9.66 9.33 3.54
TAX 0.42 4.56 -90.79 4.63 4.57 1.31 4.63 4.57 1.31
Deferred Tax -0.03 0.22 -113.64 2.12 0.22 863.64 2.12 0.22 863.64
PAT 1.96 0.34 476.47 5.03 4.76 5.67 5.03 4.76 5.67
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 82.91 360.96 -77.03 104.02 280.82 -62.96 104.02 280.82 -62.96
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..